블로그
- Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition inhibition Abstract This study investigates the transcriptional impact of Q901, a highly selective CDK7 inhibitor Q901 primarily disrupted MYC and E2F-dependent transcription program, downregulating cell cycle control
- Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer Abstract Among women The advent of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, which are dependent on cell cycle